Pathology Journals Strive Hard to Keep Up in Order to Translate Laboratory Science into Quantifiable Healthcare Benefits
SINGAPORE & LONDON (PRWEB) November 05, 2018 -- Pathological reports are central to the proper functioning of all hospitals as the discipline of pathology acts at the intersection of medicine and science, by employing cutting edge technology for better screening, diagnosis, and treatment. This branch of medicine has over 19 types of specializations, of which the most significant are chemical pathology, hematology, histopathology, immunogenetics, medical microbiology, molecular genetics, and toxicology; all of which are directed at providing accurate information on the progression of disease condition(s). Good pathology services not only benefit the patient and also ensure that the treatment procedure is much smoother for the healthcare professionals involved. Additionally, pathology also comes into play during blood storage, blood transfusion, organ storage, and vaccine development.
Like all other branches of healthcare and medicine, pathology too is subject to changes by virtue of technological advancement, and the evolving knowledge and discoveries in medicine; a case in point being digital pathology, which allows patients to interact directly with their physicians. These changes not only influence the way pathological tests are conducted, but also influence the way they are interpreted.
Increasing prevalence of chronic disorders, the ever increasing geriatric population and initiatives to prevent the occurrence and spread of infectious diseases has triggered the growth of the pathology device market. The increase in the prevalence of lifestyle diseases and sexually transmitted diseases has increased the demand for clinical chemistry and anatomical pathologies. The rise in autoimmune diseases, chromosomal disorders have precipitated the development of advanced molecular diagnostic devices. The global anatomic pathology market is projected to reach $21.9 billion by 2021 from $16.2 billion in 2016 (CAGR of 6.1%), whereas the global digital pathology market is projected to reach $887.7 million by 2025.
In this dynamic domain, journals have a central role in dispersal of information. Omics International, one of the biggest proponents of the open access movement has a significant footprint in publications pertaining to pathology, with 74 pathology related journals being published by the company. Some of these like Journal of Molecular Biomarkers & Diagnosis, Journal of Molecular and Genetic Medicine, Journal of Medical Microbiology & Diagnosis, Journal of Molecular Imaging & Dynamics, Journal of Clinical & Experimental Pathology, and Journal of Cytology & Histology hold a special position in the scholarly communication milieu.
Dr. Srinubabu Gedela, the CEO of Omics International believes that open access to pathology journals is essential for bringing about drastic changes in healthcare, especially in the context of personalized medicine.
The pathology journals published by Omics tackle topics as diverse as molecular medicine, biomarkers, DNA profiling, cytogenetics, molecular imaging, hematopathology etc. These journals not only serve as the repository of authoritative and arresting information on the latest developments and trends in pathology, but also play an important role in bringing about our vision of a healthy world to fruition.
Abhishek Babu, PULSUS GROUP, http://www.pulsus.com, +91 4047482201, [email protected]
Share this article